TmPSMA-02 in mCRPC

Clinical trial NCT06046040 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06046040
Sponsor: University of Pennsylvania
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

Start date: 2024-01-31
Primary completion: 2027-01-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.